← Leaderboards
Eva Hernando
New York University School Of Medicine
$15,270,218
Attributed
$18,471,090
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,174,390 · 17
By mechanism
R01$12,254,515 · 6
U54$8,685,745 · 5
P50$1,776,370 · 1
P01$1,455,328 · 2
R21$1,002,432 · 3
Top collaborators
- Iman Osman10 shared
- Iannis Aifantis5 shared
- Markus Schober4 shared
- Glyn Palmer2 shared
- Melanie Hayden Gephart1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Efrat Levy$16,670,052
- Ralph A. Nixon$26,583,271
- Morgan Erika Grams$12,889,441
- Vivian S Lee$14,934,720
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaNeoplasm MetastasisMolecularCellsMetastatic MelanomaTumorMelanoma CellPatient-Focused OutcomesMalignant NeoplasmsPrimary NeoplasmTissuesIn VivoNew Therapeutic TargetIn VitroGenesSamplingPhenotypeMicrornasMouse ModelBiologyBiologicalNeoplastic CellSiteDiagnosis
Grant awards (61)
NYULH Metastasis Research Network Center (NYULH MetNet Center)$1,530,347
U54 · FY2025 · CA · contact PI
Developing new therapeutic strategies for brain metastasis$548,753
R01 · FY2025 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$514,655
R01 · FY2025 · CA · contact PI
Project 4$387,979
P50 · FY2025 · CA · contact PI
Administrative Core$255,059
U54 · FY2025 · CA · contact PI
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma$255,058
U54 · FY2025 · CA · contact PI
Metabolic adaptations in melanoma brain metastasis$237,724
R21 · FY2025 · CA · contact PI
DISSECTING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN MELANOMA BONE METASTASIS$198,103
R21 · FY2025 · CA · contact PI
NYULH Metastasis Research Network Center (NYULH MetNet Center)$1,603,811
U54 · FY2024 · CA · contact PI
Developing new therapeutic strategies for brain metastasis$520,544
R01 · FY2024 · CA · contact PI
Role of circular RNA CDR1as in melanoma$511,271
R01 · FY2024 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$488,923
R01 · FY2024 · CA · contact PI
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma$314,862
U54 · FY2024 · CA · contact PI
Metabolic adaptations in melanoma brain metastasis$198,103
R21 · FY2024 · CA · contact PI
Administrative Core$132,913
U54 · FY2024 · CA · contact PI
NYULH Metastasis Research Network Center (NYULH MetNet Center)$1,654,459
U54 · FY2023 · CA · contact PI
Developing new therapeutic strategies for brain metastasis$540,115
R01 · FY2023 · CA · contact PI
Role of circular RNA CDR1as in melanoma$527,415
R01 · FY2023 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$504,361
R01 · FY2023 · CA · contact PI
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma$323,305
U54 · FY2023 · CA · contact PI
Project 4$253,399
P50 · FY2023 · CA · contact PI
Identifying and Targeting Shared Molecular Characteristics of Breast- and Melanoma-Derived Brain Metastases$175,610
U54 · FY2023 · CA
Administrative Core$174,483
U54 · FY2023 · CA · contact PI
NYULH Metastasis Research Network Center - Admin Supplement$50,850
U54 · FY2023 · CA · contact PI
Administrative Core$50,850
U54 · FY2023 · CA · contact PI
NYULH Metastasis Research Network Center (NYULH MetNet Center)$1,688,223
U54 · FY2022 · CA · contact PI
Role of circular RNA CDR1as in melanoma$554,989
R01 · FY2022 · CA · contact PI
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma$507,620
R01 · FY2022 · CA · contact PI
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma$328,933
U54 · FY2022 · CA · contact PI
Project 4$282,229
P50 · FY2022 · CA · contact PI
Administrative Core$146,982
U54 · FY2022 · CA · contact PI
Role of circular RNA CDR1as in melanoma$566,315
R01 · FY2021 · CA · contact PI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$342,005
P01 · FY2021 · CA · contact PI
Project 4$282,230
P50 · FY2021 · CA · contact PI
Role of circular RNA CDR1as in melanoma$549,348
R01 · FY2020 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2020 · CA
Project 4$288,300
P50 · FY2020 · CA · contact PI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$105,854
P01 · FY2020 · CA · contact PI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$11,996
P01 · FY2020 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$445,719
R01 · FY2019 · CA
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$321,889
P01 · FY2019 · CA · contact PI
Project 4$282,233
P50 · FY2019 · CA · contact PI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$9,299
P01 · FY2019 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2018 · CA
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$360,411
P01 · FY2018 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2017 · CA
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis$351,713
R01 · FY2017 · CA · contact PI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients$303,874
P01 · FY2017 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$445,437
R01 · FY2016 · CA
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis$351,713
R01 · FY2016 · CA · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$350,851
R01 · FY2016 · CA · contact PI
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis$351,713
R01 · FY2015 · CA · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$350,851
R01 · FY2015 · CA · contact PI
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis$341,161
R01 · FY2014 · CA · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$340,325
R01 · FY2014 · CA · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$162,573
R01 · FY2014 · CA · contact PI
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis$351,713
R01 · FY2013 · CA · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$329,801
R01 · FY2013 · CA · contact PI
Multilineage regulation of mesenchymal stem cell differentiation by microRNAs$179,508
R21 · FY2013 · AR · contact PI
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma$368,121
R01 · FY2012 · CA · contact PI
Multilineage regulation of mesenchymal stem cell differentiation by microRNAs$188,994
R21 · FY2012 · AR